Opzelura 1.5% Cream (Ruxolitinib 1.5% Cream)

– Apply thin layer of cream to affected areas twice daily of up to 20% body surface area for topical short-term and non-continuous long-term treatment of mild-to-moderate atopic dermatitis in non-immunocompromised adults whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable

– Stop using when signs and symptoms (itch, rash, redness) of atopic dermatitis resolve

– If signs and symptoms do not improve within 8 weeks, re-examine patient

Maximum Dose: 60 gram/week or 100 gram/2 weeks